Galc-flox 基因敲除小鼠

1. Senkevich, Konstantin, Zorca, Cornelia E, Dworkind, Aliza, Alcalay, Roy N, Gan-Or, Ziv. . GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease. In Brain : a journal of neurology, 146, 1859-1872. doi:10.1093/brain/awac413. https://pubmed.ncbi.nlm.nih.gov/36370000/

2. Maghazachi, Azzam A. 2023. Globoid Cell Leukodystrophy (Krabbe Disease): An Update. In ImmunoTargets and therapy, 12, 105-111. doi:10.2147/ITT.S424622. https://pubmed.ncbi.nlm.nih.gov/37928748/

3. Zhao, Yinghai, Guo, Ying, Wang, Zhijing, Du, Haijun, Zeng, Yi. 2015. GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma. In Oncology reports, 34, 1369-78. doi:10.3892/or.2015.4134. https://pubmed.ncbi.nlm.nih.gov/26178533/

4. Herdt, Aimee R, Peng, Hui, Dickson, Dennis W, Eckman, Elizabeth A, Lee, Chris W. 2023. Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease. In Genes, 14, . doi:10.3390/genes14081517. https://pubmed.ncbi.nlm.nih.gov/37628569/

5. Kia, Demis A, Zhang, David, Guelfi, Sebastian, Hardy, John, Wood, Nicholas W. . Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets. In JAMA neurology, 78, 464-472. doi:10.1001/jamaneurol.2020.5257. https://pubmed.ncbi.nlm.nih.gov/33523105/